Negative Correlation Between Metabolic Score for Insulin Resistance Index and Testosterone in Male Adults
Overview
Authors
Affiliations
Background: Insulin resistance (IR) is strongly correlated with the decreased deficiency of testosterone levels in males. The metabolic score for insulin resistance (METS-IR) index is regarded as an innovative measure for the assessment on IR. The research aims to explore the correlation between the METS-IR index and the testosterone levels in males.
Methods: In this study, a cross-sectional design was made through the data obtained from the National Health and Nutrition Examination Survey (NHANES) from 2013 to 2020. Besides, the METS-IR index was derived from serum triglyceride levels, fasting plasma glucose, HDL-C and BMI.
Results: A total of 2082 participants were included in the final analysis. After controlling for confounding variables, it was found that METS-IR was independently and negatively correlated with testosterone levels (β = -3.88, 95% CI = -4.49, -3.27, P < 0.001). As shown by the generalized smooth curve fitting, METS-IR had a linear correlation with testosterone levels without threshold or saturation effects, which was consistently observed across all subgroups through stratified analysis (all P > 0.05). As revealed by the analysis on the ROC curve, the area under the curve (AUC) for the METS-IR index (0.732, 95% CI = 0.705, 0.760) was significantly larger than that of homeostatic model assessment of insulin resistance (HOMA-IR), TG/HDL ratio, triglyceride-glucose index (TyG) and body mass index (BMI).
Conclusion: The findings suggest a negative relationship between the METS-IR index and the testosterone levels in male adults. Furthermore, the METS-IR index demonstrates superior predictive ability for testosterone deficiency in comparison to HOMA-IR, TG/HDL ratio, TyG and BMI.
Association between METS-IR index and obstructive sleep apnea: evidence from NHANES.
Yin H, Huang W, Yang B Sci Rep. 2025; 15(1):6654.
PMID: 39994225 PMC: 11850641. DOI: 10.1038/s41598-024-84040-9.
Shangguan T, Xu J, Weng X, Lin H Front Psychiatry. 2025; 16:1504123.
PMID: 39950171 PMC: 11821614. DOI: 10.3389/fpsyt.2025.1504123.
Zhang M, Lin H, Xu X BMC Public Health. 2025; 25(1):497.
PMID: 39915803 PMC: 11804045. DOI: 10.1186/s12889-025-21734-3.
Xing D, Xu J, Weng X, Weng X Diabetol Metab Syndr. 2025; 17(1):11.
PMID: 39780246 PMC: 11714986. DOI: 10.1186/s13098-024-01574-8.
Mei Y, Zhang B, Wang X, Xu R, Xia W, Chen Y BMC Public Health. 2025; 25(1):41.
PMID: 39762770 PMC: 11702022. DOI: 10.1186/s12889-024-21230-0.